Johnson & Johnson (JNJ) Long-Term Debt Issuances (2009 - 2025)
Johnson & Johnson's (JNJ) quarterly Long-Term Debt Issuances came in at $9.1 billion in Q1 2025, up 456800.0% year-over-year from N/an in Q1 2024, and up 913700.0% quarter-over-quarter from $1.0 million in Q3 2024.
Analysis
Johnson & Johnson (JNJ) Long-Term Debt Issuances (2009 - 2025) Analysis & Trends
Johnson & Johnson has disclosed Long-Term Debt Issuances across 15 years of filings, most recently posting $9.1 billion for Q1 2025.
- In Q1 2025, Long-Term Debt Issuances rose 456800.0% year-over-year to $9.1 billion; the TTM figure through Dec 2025 stood at $9.1 billion (up 37.21% YoY), while the FY2025 annual figure was $9.1 billion, up 37.21% from the prior year.
- Long-Term Debt Issuances came in at $9.1 billion for Q1 2025 at Johnson & Johnson, up from $1.0 million in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $9.1 billion in Q1 2025 to a low of -$7.7 billion in Q4 2023.
- Average Long-Term Debt Issuances over 4 years is $1.8 billion, with a median of $2.0 million recorded in 2021.
- Year-over-year, Long-Term Debt Issuances slumped 99.97% in 2024 and jumped 456800.0% in 2025.
- Over 4 years, Long-Term Debt Issuances stood at $2.0 million in 2021, then sank by 383800.0% to -$7.7 billion in 2023, then soared by 100.01% to $1.0 million in 2024, then surged by 913700.0% to $9.1 billion in 2025.
- Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $9.1 billion in Q1 2025, $1.0 million in Q3 2024, and $6.7 billion in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | - |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 1.98 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 4.88 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | - |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 30, 2025 | 9.14 Bn |
| Sep 29, 2024 | 1.00 Mn |
| Jun 30, 2024 | 6.66 Bn |
| Mar 31, 2024 | 2.00 Mn |
| Oct 1, 2023 | -7.67 Bn |
| Apr 2, 2023 | 7.67 Bn |
| Jan 1, 2023 | -1.00 Mn |
| Oct 3, 2021 | 2.00 Mn |
| Apr 4, 2021 | 1.00 Mn |
| Sep 27, 2020 | 7.43 Bn |
| Jun 28, 2020 | 1.00 Mn |
| Dec 29, 2019 | 2.00 Mn |
| Jun 30, 2019 | 1.00 Mn |
| Dec 30, 2018 | -1.00 Mn |
| Sep 30, 2018 | 3.00 Mn |
| Jul 1, 2018 | 1.00 Mn |
| Apr 1, 2018 | 2.00 Mn |
| Dec 31, 2017 | 4.53 Bn |
| Oct 1, 2017 | 1.00 Mn |
| Apr 2, 2017 | 4.46 Bn |